GoodRx Holdings (GDRX) EV to EBITDA (2020 - 2026)

GoodRx Holdings has disclosed EV to EBITDA across 7 years of filings, most recently posting 28.92 for Q2 2026.

• In Q2 2026, EV to EBITDA fell 47.45% year-over-year to 28.92; the TTM figure through Jun 2026 stood at 9.12 (down 45.13% YoY), while the FY2025 annual figure was 7.22, down 61.84% from the prior year.
• EV to EBITDA came in at 28.92 for Q2 2026 at GoodRx Holdings, down from 30.4 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 629.23 in Q4 2022 to a low of 401.55 in Q2 2022.
• Average EV to EBITDA over 5 years is 80.94, with a median of 64.22 recorded in 2024.
• Year-over-year, EV to EBITDA sank 117.1% in 2023 and surged 387.86% in 2024.
• Over 5 years, EV to EBITDA stood at 629.23 in 2022, then sank by 117.1% to 107.62 in 2023, then surged by 168.07% to 73.25 in 2024, then tumbled by 60.13% to 29.2 in 2025, then retreated by 0.97% to 28.92 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 28.92 in Q2 2026, 30.4 in Q1 2026, and 29.2 in Q4 2025.